ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,427, issued on June 17, was assigned to Twist Bioscience Corp. (South San Francisco, Calif.).
"Antibodies that bind GLP1R" was invented by Ray Tabibiazar (Chattanooga, Tenn.), Aaron Sato (Burlingame, Calif.), Pankaj Garg (Burlingame, Calif.), Qiang Liu (Palo Alto, Calif.) and Fumiko Axelrod (Palo Alto, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods and compositions relating to glucagon-like peptide-1 receptor (GLP1R) libraries having nucleic acids encoding for a scaffold comprising a GLP1R binding domain. Libraries described herein include variegated libraries comprising nucleic acids each encoding for a predetermi...